If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
572.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (0.176%)
Market Cap: £1.55b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

Directorate Change

24 Jun 2014 07:00

RNS Number : 3280K
Chemring Group PLC
24 June 2014
 



 FOR IMMEDIATE RELEASE 24 JUNE 2014

 

CHEMRING GROUP PLC

 

Directorate change

 

Michael Flowers appointed Group Chief Executive

 

Chemring Group PLC ("Chemring" or "the Group") announces that Michael Flowers has been appointed Group Chief Executive with immediate effect. Michael joined Chemring in 2006 and prior to today's appointment was Group Director, Countermeasures and a member of Chemring's Executive Committee.

 

Michael Flowers has spent 13 years in senior management positions within the defence industry. He previously served as an officer in the Australian Army for 22 years and was a graduate of the Australian Command and Staff College and the British Royal Military College of Science. After leaving the army, he was a senior manager at BAE Systems from 2001 to 2006, in programme and project management roles.

 

From 2006, he was Managing Director, Chemring Australia, where he established a state of the art countermeasures manufacturing facility and delivered substantial growth in the defence portfolio. In 2013, he was appointed Group Director, Munitions, with responsibility for Chemring's European munitions business. Michael led the successful sale of the European munitions business following the 2013 strategic review, working closely with Chemring's Board and advisers to negotiate and complete the disposal in May 2014.

 

Mark Papworth has stepped down from the Board of Chemring with immediate effect. 

 

Peter Hickson, Chairman of Chemring, said:

 

"Michael Flowers has a proven track record, both within the international defence industry and within Chemring, where he led our Australian business through a successful period of growth and, more recently, managed the complex disposal process of the European munitions business. Michael is extremely knowledgeable about our markets and is well qualified to lead Chemring as we capitalise on our world leading technologies in Countermeasures, Sensors & Electronics and Energetic Systems.

 

Much has been achieved during Mark Papworth's tenure, including a significant reorganisation and refocusing of the Group and a substantial reduction in the cost base and we are grateful for his leadership during this period.

 

We are now moving from a period of critical and significant change to one where we must take maximum advantage of the stronger platform that has been created. To achieve this, a different set of skills is required in the role of Chief Executive, in particular extensive knowledge and understanding of the defence markets in which we operate."

 

Michael Flowers has a beneficial shareholding of 80,680 Chemring shares.

 

There is no further information to be disclosed pursuant to paragraph 9.6.13R of the UK Listing Rules in relation to Michael Flowers' appointment as a director of Chemring.

 

Ends

 

 

 

 

For further information, contact:

 

Chemring Group PLC 01489 881 880

Peter Hickson, Chairman

Steve Bowers, Finance Director

Rupert Pittman, Group Director of Communications and Investor Relations

 

MHP Communications 020 3128 8100

Andrew Jaques

John Olsen

James White

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADDGDLSBDBGSX
Date   Source Headline
27th Jan 201512:08 pmRNSDirector/PDMR Shareholding
27th Jan 201512:03 pmRNSDirector/PDMR Shareholding
23rd Jan 20154:33 pmRNSDirector Declaration
22nd Jan 20157:00 amRNSFULL YEAR RESULTS
2nd Jan 201512:59 pmRNSTotal Voting Rights
30th Dec 20147:00 amRNSDirectorate Change
19th Dec 201410:26 amRNSBlocklisting Interim Review
1st Dec 20141:26 pmRNSHolding(s) in Company
1st Dec 20141:22 pmRNSTotal Voting Rights
25th Nov 20147:00 amRNSPOST-CLOSE STATEMENT
3rd Nov 20142:36 pmRNSTotal Voting Rights
1st Oct 201410:04 amRNSTotal Voting Rights
17th Sep 20147:00 amRNSInterim Management Statement
1st Sep 20142:52 pmRNSTotal Voting Rights
8th Aug 201412:28 pmRNSDirector/PDMR Shareholding
1st Aug 201410:34 amRNSTotal Voting Rights
21st Jul 201410:03 amRNSDirector/PDMR Shareholding
9th Jul 201411:57 amRNSDirector/PDMR Shareholding
2nd Jul 20147:30 amRNSHolding(s) in Company
1st Jul 201412:10 pmRNSDirector/PDMR Shareholding
1st Jul 20149:38 amRNSHolding(s) in Company
1st Jul 20149:00 amRNSChange of Registered Office
24th Jun 20147:00 amRNSDirectorate Change
24th Jun 20147:00 amRNSHalf Yearly Report
18th Jun 201411:00 amRNSBlocklisting Interim Review
30th May 20144:59 pmRNSTotal Voting Rights
27th May 20143:29 pmRNSHolding(s) in Company
27th May 20142:37 pmRNSCompletion of Disposal of European Munitions
22nd May 20147:00 amRNSUpdate on Disposal
12th May 20149:40 amRNSResult of EGM
9th May 20147:00 amRNSACQUISITION OF 3D-RADAR
1st May 201412:18 pmRNSTotal Voting Rights
30th Apr 201411:34 amRNSDirector/PDMR Shareholding
29th Apr 20141:20 pmRNSDirector/PDMR Shareholding
29th Apr 201412:42 pmRNSPDMR Shareholding
29th Apr 201411:59 amRNSDirector/PDMR Shareholding
29th Apr 201411:58 amRNSDirector/PDMR Shareholding
29th Apr 201411:57 amRNSDirector/PDMR Shareholding
29th Apr 201411:14 amRNSHolding(s) in Company
24th Apr 20144:30 pmRNSPublication of Circular
24th Apr 20147:00 amRNSDisposal
15th Apr 201412:11 pmRNSDirector Declaration
14th Apr 201411:15 amRNSBlocklisting update
9th Apr 201410:12 amRNSAdditional Listing
26th Mar 20144:16 pmRNSDoc re. Ordinary & Special Resolutions
20th Mar 20142:04 pmRNSResult of AGM
3rd Mar 201410:11 amRNSTotal Voting Rights
27th Feb 20147:00 amRNSInterim Management Statement
6th Feb 201412:18 pmRNSHolding(s) in Company
3rd Feb 201410:43 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.